120 related articles for article (PubMed ID: 36605103)
21. B7-H3 confers resistance to Vγ9Vδ2 T cell-mediated cytotoxicity in human colon cancer cells via the STAT3/ULBP2 axis.
Lu H; Ma Y; Wang M; Shen J; Wu H; Li J; Gao N; Gu Y; Zhang X; Zhang G; Shi T; Chen W
Cancer Immunol Immunother; 2021 May; 70(5):1213-1226. PubMed ID: 33119798
[TBL] [Abstract][Full Text] [Related]
22. B7-H3, B7-H4, Foxp3 and IL-2 expression in cervical cancer: Associations with patient outcome and clinical significance.
Huang C; Zhou L; Chang X; Pang X; Zhang H; Zhang S
Oncol Rep; 2016 Apr; 35(4):2183-90. PubMed ID: 26848032
[TBL] [Abstract][Full Text] [Related]
23. Clinical Significance of B7-H3 Expression During the Progression of Hepatitis B Virus Infection.
Gao F; Xu JC; Zhu L; Chen H; Zhu XY; You XR; Li SX; Zhu CL; Yang C; Zhu CW; Xu P
Viral Immunol; 2018 Dec; 31(10):668-675. PubMed ID: 30481143
[TBL] [Abstract][Full Text] [Related]
24. B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome.
Ingebrigtsen VA; Boye K; Nesland JM; Nesbakken A; Flatmark K; Fodstad Ø
BMC Cancer; 2014 Aug; 14():602. PubMed ID: 25139714
[TBL] [Abstract][Full Text] [Related]
25. B7-H3 expression in upper tract urothelial carcinoma associates with adverse clinicopathological features and poor survival.
Koyama Y; Morikawa T; Miyama Y; Miyakawa J; Kawai T; Kume H; Sawabe M; Ushiku T
Pathol Res Pract; 2020 Dec; 216(12):153219. PubMed ID: 33049447
[TBL] [Abstract][Full Text] [Related]
26. [Expression and clinical significance of soluble B7-H3 in sera of patients with primary hepatocellular carcinoma].
Wang F; Yu G; Liu T; Wang G; Yang J; Zhang G; Luan X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jun; 29(6):629-32. PubMed ID: 23746248
[TBL] [Abstract][Full Text] [Related]
27. B7-H3 expression in ductal and lobular breast cancer and its association with IL-10.
Liu C; Liu J; Wang J; Liu Y; Zhang F; Lin W; Gao A; Sun M; Wang Y; Sun Y
Mol Med Rep; 2013 Jan; 7(1):134-8. PubMed ID: 23128494
[TBL] [Abstract][Full Text] [Related]
28. Reduced serum B7-H3 levels in patients with ankylosing spondylitis.
Yan R; Hu Y; Yu P; Wen H; Feng P; Yang S
Inflammation; 2015; 38(3):1322-8. PubMed ID: 25567370
[TBL] [Abstract][Full Text] [Related]
29. An orthotopic colon cancer model for studying the B7-H3 antitumor effect in vivo.
Lupu CM; Eisenbach C; Kuefner MA; Schmidt J; Lupu AD; Stremmel W; Encke J
J Gastrointest Surg; 2006 May; 10(5):635-45. PubMed ID: 16713537
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis value of serum B7-H3 expression in non-small cell lung cancer.
Zhang G; Xu Y; Lu X; Huang H; Zhou Y; Lu B; Zhang X
Lung Cancer; 2009 Nov; 66(2):245-9. PubMed ID: 19269710
[TBL] [Abstract][Full Text] [Related]
31. B7-H3 overexpression in pancreatic cancer promotes tumor progression.
Zhao X; Li DC; Zhu XG; Gan WJ; Li Z; Xiong F; Zhang ZX; Zhang GB; Zhang XG; Zhao H
Int J Mol Med; 2013 Feb; 31(2):283-91. PubMed ID: 23242015
[TBL] [Abstract][Full Text] [Related]
32. B7-H3, Negatively Regulated by miR-128, Promotes Colorectal Cancer Cell Proliferation and Migration.
Hu X; Xu M; Hu Y; Li N; Zhou L
Cell Biochem Biophys; 2021 Jun; 79(2):397-405. PubMed ID: 33743142
[TBL] [Abstract][Full Text] [Related]
33. B7-H3 promotes the proliferation, migration and invasiveness of cervical cancer cells and is an indicator of poor prognosis.
Li Y; Zhang J; Han S; Qian Q; Chen Q; Liu L; Zhang Y
Oncol Rep; 2017 Aug; 38(2):1043-1050. PubMed ID: 28627681
[TBL] [Abstract][Full Text] [Related]
34. Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC).
Carvajal-Hausdorf D; Altan M; Velcheti V; Gettinger SN; Herbst RS; Rimm DL; Schalper KA
J Immunother Cancer; 2019 Mar; 7(1):65. PubMed ID: 30850021
[TBL] [Abstract][Full Text] [Related]
35. Assessment of plasma B7-H3 levels in pediatric patients with different degrees of surgical stress.
Li Y; Yuan Q; Huang J; Li YP; Pan J; Feng X; Zhang XG; Wang JH; Wang J
BMC Pediatr; 2016 Jul; 16():110. PubMed ID: 27459969
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the role of B7-H3 haplotype in association with impaired B7-H3 expression and protection against type 1 diabetes in Chinese Han population.
Ding S; Shan Y; Sun L; Li S; Jiang R; Chang X; Huang Z; Sun J; Liu C; Fang C; Zhang X
BMC Endocr Disord; 2020 Aug; 20(1):123. PubMed ID: 32787907
[TBL] [Abstract][Full Text] [Related]
37. Molecular imaging of T cell co-regulator factor B7-H3 with
Burvenich IJG; Parakh S; Lee FT; Guo N; Liu Z; Gan HK; Rigopoulos A; O'Keefe GJ; Gong SJ; Goh YW; Tochon-Danguy H; Scott FE; Kotsuma M; Hirotani K; Senaldi G; Scott AM
Theranostics; 2018; 8(15):4199-4209. PubMed ID: 30128047
[TBL] [Abstract][Full Text] [Related]
38. The co-stimulatory molecule B7-H3 promotes the epithelial-mesenchymal transition in colorectal cancer.
Jiang B; Zhang T; Liu F; Sun Z; Shi H; Hua D; Yang C
Oncotarget; 2016 May; 7(22):31755-71. PubMed ID: 27145365
[TBL] [Abstract][Full Text] [Related]
39. Soluble B7-H3 in Ovarian Cancer and Its Predictive Value.
Kovaleva OV; Belova TP; Korotkova EA; Kushlinskii DN; Gratchev AN; Petrikova NA; Kudlay DA; Kushlinskii NE
Bull Exp Biol Med; 2021 Aug; 171(4):472-474. PubMed ID: 34542756
[TBL] [Abstract][Full Text] [Related]
40. Effects of B7-H3 expression on tumour-infiltrating immune cells and clinicopathological characteristics in non-small-cell lung cancer.
Yim J; Koh J; Kim S; Song SG; Ahn HK; Kim YA; Jeon YK; Chung DH
Eur J Cancer; 2020 Jul; 133():74-85. PubMed ID: 32447027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
